Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

172
Delayed Quote. Delayed BATS Europe - 10/24 11:30:00 am
85.75 CHF   +0.41%
1d agoDJNovartis 3Q 2014 -- Forecast
1d ago NOVARTIS : reports positive results in spinal inflammation condition
1d ago NOVARTIS : AIN457 (secukinumab) meets primary endpoint in two Phase III stu..
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on NOVARTIS AG
10/03 EU Commission clears Eli Lilly, Novartis deal
10/03DJNOVARTIS : EU Approves Acquisition of Novartis Animal Health Division by Eli Lil..
10/02 EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal - sources
10/02 NOVARTIS : announces Skin Impressions campaign launch on the first International..
10/02 NOVARTIS : to tackle climate change with Sichuan tree planting project
10/01 NOVARTIS : to face US legal action
10/01 NESTLERFD : VGK, EFO: Big ETF Outflows
10/01 NOVARTIS : SDNY Denies Novartis' Motion to Dismiss Kickback Lawsuit Under False ..
10/01 NOVARTIS : reports 3,878 suspected cases of drug side effects
10/01 NOVARTIS : announces Skin Impressions campaign launch on the first International..
10/01 NOVARTIS : Reports Results on Overall Survival from Phase III of Afinitor
10/01 Plant-based vaccines challenge big pharma for $3 billion flu market
10/01 NOVARTIS : showcases dermatology leadership on International Urticaria Day annou..
10/01 NOVARTIS : showcases dermatology leadership on International Urticaria Day annou..
10/01 NOVARTIS : showcases dermatology leadership on International Urticaria Day annou..
09/30 NESTLERFD : VEU, SRTY: Big ETF Inflows
09/30 NOVARTIS : Alcon Research Assigned Patent
09/29 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
09/29 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
09/29 NOVARTIS : drug Signifor LAR recommended by CHMP for EU approval to treat patien..
09/29 NOVARTIS : Patients lived average of 18 months without cancer progressing when t..
09/29 NOVARTIS : drug Afinitor is first treatment for advanced pancreatic NET to provi..
09/28 NOVARTIS : Eye Surgery Equipment Sought by Veterans Affairs
09/27 NOVARTIS : Patients lived average of 18 months without cancer progressing when t..
09/27 NOVARTIS : Patients lived average of 18 months without cancer progressing when t..
09/27 NOVARTIS : Patients lived average of 18 months without cancer progressing when t..
09/27 NOVARTIS : drug Afinitor is first treatment for advanced pancreatic NET to provi..
09/27 NOVARTIS : drug Afinitor is first treatment for advanced pancreatic NET to provi..
09/27 NOVARTIS : drug Afinitor is first treatment for advanced pancreatic NET to provi..
09/26 NOVARTIS : Strewth! Cyclists clock-up two return trips to Oz ; When we asked you..
09/26 NOVARTIS : and the NHS work together to improve sight loss services for local pe..
09/26 NOVARTIS : Retroscreen Virology Group Announces Half -Year Financial Report
09/26 NOVARTIS : drug Signifor® LAR recommended by CHMP for EU approval to treat patie..
09/26 NOVARTIS : drug Signifor® LAR recommended by CHMP for EU approval to treat patie..
09/26 NOVARTIS : drug Signifor® LAR recommended by CHMP for EU approval to treat patie..
09/25 NOVARTIS : NAPSRx Investigates: New Heart Failure Drug Reduces Cardiovascular De..
09/25 NOVARTIS : NAD Recommends Alcon Discontinue Certain Claims for Air Optix Aqua Co..
09/25 GlaxoSmithKline appoints RBS's Hampton as next chairman
09/25DJGlaxo Names RBS's Hampton as Chairman
09/25 NOVARTIS : AIN457 (secukinumab) is the first ever IL-17A inhibitor to meet prima..
09/25 NOVARTIS : AIN457 (secukinumab) is the first ever IL-17A inhibitor to meet prima..
09/25 NOVARTIS : AIN457 (secukinumab) is the first ever IL-17A inhibitor to meet prima..
09/24 Adaptimmune raises $104 million to develop immune-system cancer drugs
09/23 NOVARTIS : Provectus Biopharmaceuticals Appoints Christopher Kaplan to Its Strat..
09/23 NOVARTIS : Alcon Research Assigned Patent
09/23 NOVARTIS : Ride for Life: Almost $1 million raised by Novartis employees for bre..
09/22DJGermany's Merck to Buy Sigma-Aldrich for $17 Billion--3rd Update
09/22 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
09/22 Germany's Merck to buy Sigma-Aldrich for $17 billion to boost lab supplies op..
09/22 Germany's Merck to buy Sigma-Aldrich for $17 billion to boost lab supplies op..
09/22DJGermany's Merck to Buy Sigma-Aldrich for $17 Billion--2nd Update
09/22DJGermany's Merck to Buy Sigma-Aldrich for $17 Billion--Update
09/22 After China, GlaxoSmithKline faces pressure for change
09/22 NOVARTIS : Adaptive Biotechnologies Names Genoptix and Gen-Probe Exec Brian Hans..
09/18 NOVARTIS : data in The Lancet Oncology show LBH589 offers 4-month increase in me..
09/18 NOVARTIS : data in The Lancet Oncology show LBH589 offers 4-month increase in me..
09/18 Bayer hits record high on move to list plastics business
09/18 NOVARTIS : Keep eye health in vision
09/17 PAUL ALLEN : Patent Issued for Crystalline Forms of 4-Methyl-N--3-(4-Pyr-...
09/17 For Roche CEO, celebrating failure is key to success
09/17 Court grants novartis temporary injunction against ranbaxy
09/17 NOVARTIS : to tackle climate change with Sichuan tree planting project
09/17 NOVARTIS : presents oncology research advances with new data on Zykadia(TM), Afi..
09/17 NOVARTIS : presents oncology research advances with new data on Zykadia(TM), Afi..
09/16 NOVARTIS : China Valsartan Hydrochlorothiazide Market Analysis & Forecast Resear..
09/16 NOVARTIS : Ari Gnanasakthy, Karoly Kulich Join RTI Health Solutions Adding Decad..
09/15 NOVARTIS : CONTRACT AWARD - 65-- Oxazepam Capsules Sandoz, Inc Effective: 9/22/2..
09/15 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
09/15 NESTLERFD : VGK, DUST: Big ETF Outflows
09/15 EU to decide on $52 billion AbbVie, Shire deal by Oct. 16
09/15 NOVARTIS : New data confirm high efficacy of Gilenya in achieving 'no evidence o..
09/14 NOVARTIS : grows by 15%: CPO Head and Country President
09/13 NOVARTIS : demonstrates leadership in ophthalmology with new products and over 4..
09/13 NOVARTIS : demonstrates leadership in ophthalmology with new products and over 4..
09/12 NOVARTIS : Center for Advanced Cellular Therapeutics to Rise on Penn Medicine Ca..
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF